Concepedia

Lucie Bibeau

LB

Statistics

Publications

3

Citations

108

H-Index

3

Active since

1997

Affiliations

BioPhage Pharma (Canada)(Current)

Lucie Bibeau is an author at BioPhage Pharma (Canada) specializing in medicine, pharmacology, and medicinal chemistry.

Top concepts

Publications per year

1997–2002

3

Publications

3

Potent antitumor activity of a novel nucleoside analogue, BCH-4556 (beta-L-dioxolane-cytidine), in human renal cell carcinoma xenograft tumor models.

S. A. Kadhim, Terry L. Bowlin, William R. Waud et al. · PubMed · 1997 · 54 citations

, , +15

Comparative study of a novel nucleoside analogue (Troxatyl, troxacitabine, BCH-4556) and AraC against leukemic human tumor xenografts expressing high or low cytidine deaminase activity

Henriette Gourdeau, Lucie Bibeau, France Ouellet et al. · Cancer Chemotherapy and Pharmacology · 2001 · 40 citations

, , +9

Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts

Henriette Gourdeau, Philippe Genne, Salam Kadhim et al. · Cancer Chemotherapy and Pharmacology · 2002 · 14 citations

, , +5

1–3 of 3